Resource Center Medical Weight Loss in a Med Spa Practice Navigate the legal, regulatory, and clinical landscape of GLP-1 medications including semaglutide and tirzepatide in your medical aesthetic practice
In the obesity trials, participants on the 12 mg dose reached up to roughly 2829% mean body-weight reduction at 68 to 80 weeks, with a large share crossing the 25% and 30% thresholds, the strongest weight result reported for a GLP-1-class compound in a phase 3 trial [5]
doi: 10.1073/pnas.2332354100 59 OMalleyYQAbdallaMYMcCormickMLReszkaKJDenningGMBritiganBEet al
A 5 mg vial dosage chart , a 5 mg/mL concentration chart , a 10 mg dosage chart , and a general compounded dose chart all provide the same fundamental information formatted for different starting points
doi: 10.2337/db09-0063 40 ArakawaMEbatoCMitaTHiroseTKawamoriRFujitaniYet al